Latest Paracetamol Stories
WASHINGTON, July 31, 2014 /PRNewswire-USNewswire/ -- Today's Consumer Reports story on prescription and non-prescription pain relievers serves as an important reminder for consumers of the importance
LONDON, July 30, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc.
The Firm is investigating Tylenol lawsuits on behalf of individuals who may have suffered serious liver damage due to the acetaminophen in Tylenol over-the-counter medications. New
The Firm is investigating Tylenol lawsuits on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to Tylenol-brand over-the-counter products. New
Paracetamol is no better than placebo at speeding recovery from acute episodes of lower back pain or improving pain levels, function, sleep, or quality of life.
The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered acetaminophen liver damage, allegedly due to Tylenol-brand medications. New
First and only FDA approved naloxone product specifically indicated for emergency therapy in settings where opioids may be present. RICHMOND, Va., July 10, 2014 /PRNewswire/ -- Kaleo, a privately-held
Name Change to Reflect the Operations of the Company after the Completion of the Public Transaction NEW YORK, July 9, 2014 /PRNewswire/ -- Camp Nine, Inc., (OTCBB: CMPE), a Nevada
DUBLIN, July 8, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S.
Anticipated FDA action set for October 2014 STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S.